Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy

Vismodegib is approved for the treatment of adult patients with metastatic (mBCC) or locally advanced basal cell carcinoma (laBCC) that have recurred following surgery or for those who are not good candidates for surgery (risk/benefit ratio is against patient’s benefit, either because of the general...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cosmet Investig Dermatol
Main Authors: Apalla, Zoe, Papageorgiou, Chrysoula, Lallas, Aimilios, Sotiriou, Elena, Lazaridou, Elizabeth, Vakirlis, Efstratios, Kyrgidis, Athanassios, Ioannides, Demetrios
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436682/
https://ncbi.nlm.nih.gov/pubmed/28546761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S101330
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados